In an early study by Klampfl et al., amongst 1107 patients with MPN, CALR mutations were identified in 25% ET and 35% PMF patients, but not in PV patients or other myeloid neoplasms [8]. This evidence concerns the gene CALR and acquired polycythemia vera.